🎧 Audio
📖 Script
Many biotechnology companies are now choosing to list their stocks in Hong Kong instead of traditional markets like Wall Street. A key reason for this shift is Hong Kong’s growing number of investors who are interested in the biotech sector. These investors provide a strong financial backing for companies looking to expand and innovate. Moreover, being in Hong Kong places these companies closer to Chinese pharmaceutical partners, which is beneficial for collaborations and partnerships. China is a significant player in the global pharmaceutical industry, and having a presence in Hong Kong can open doors to this vast market.
The decision to list in Hong Kong is also influenced by the favorable policies that support biotech firms. The Hong Kong Stock Exchange offers a supportive environment for these companies, with regulations that encourage innovation and growth. This makes it an attractive location for companies that are looking to raise capital and increase their visibility in the Asian market.
One American biotech firm recently decided to list in Hong Kong for these reasons. The company believes that Hong Kong offers better opportunities for growth due to its strategic location and access to the Asian market. By listing there, the firm aims to attract more investors and strengthen its partnerships with Chinese companies.
Another factor contributing to this trend is the increasing demand for healthcare and biotechnology products in Asia. As the population in Asia continues to grow, so does the need for advanced medical treatments and drugs. This demand creates a lucrative market for biotech firms, making Hong Kong an ideal place to establish a foothold.
Overall, the shift towards listing in Hong Kong reflects the growing importance of Asia in the global biotech industry. Companies are recognizing the benefits of being close to key markets and partners, and Hong Kong provides an excellent platform for achieving these goals. As more firms make this move, it is likely to strengthen Hong Kong’s position as a leading hub for biotech innovation and investment.
📝 Vocabulary
- investor: a person who puts money into a business to make a profit（投資家）
例文: “The investor was pleased with the company’s growth.”
Collocations／日本語の意味を見る
- attract investors
- foreign investors
- private investors
- pharmaceutical: relating to drugs developed for medical use（製薬の）
例文: “The pharmaceutical company launched a new drug.”
Collocations／日本語の意味を見る
- pharmaceutical industry
- pharmaceutical companies
- pharmaceutical research
- collaboration: working together with others to achieve a common goal（協力）
例文: “Successful collaboration led to the project’s success.”
Collocations／日本語の意味を見る
- in collaboration with
- collaboration between
- foster collaboration
- regulation: rules or directives made and maintained by an authority（規制）
例文: “New regulations have been introduced to ensure safety.”
Collocations／日本語の意味を見る
- government regulation
- environmental regulation
- strict regulation
- strategic: carefully designed or planned to serve a particular purpose or advantage（戦略的な）
例文: “The company made a strategic decision to expand abroad.”
Collocations／日本語の意味を見る
- strategic plan
- strategic location
- strategic partnership
✏️ Grammar Point
Relative Clause – “The company believes that Hong Kong offers better opportunities for growth due to its strategic location and access to the Asian market.”
文法の日本語補足を見る
💡 使用場面
この構文は、情報を追加して説明を詳しくする際に使われます。例: ビジネスプレゼンテーションで「この製品は、環境に優しい素材で作られているため、人気があります。」と言うとき。
📝 使用例文
“例: In a business meeting, you might say: ‘If we cut costs now, we can increase our profit margin next quarter.’”
❓ Listening Questions
- True/False: Biotechnology companies are moving to list in Hong Kong because of its proximity to European partners.
- MCQ: What is one reason biotech companies choose Hong Kong for listing?
a) Lower taxes
b) Better weather
c) Growing investor interest
d) Proximity to American partners - MCQ: What benefit does Hong Kong offer to biotech firms?
a) Access to European markets
b) Strategic location close to China
c) Higher stock prices
d) Fewer competitors
🔑 Listening Answersを見る
- False
- c) Growing investor interest
- b) Strategic location close to China
📚 Reading Questions
- What is a key reason for biotech firms listing in Hong Kong?
- Why do you think being close to Chinese pharmaceutical partners is important for these companies?
- What does the word “collaborations” mean in the context of the script?
🔑 Reading Answersを見る
- Hong Kong’s growing number of investors interested in the biotech sector.
- Being close to Chinese partners can enhance collaborations and access to a large market.
- Working together with others to achieve a common goal.
🇯🇵 日本語での経済ニュース解説
最近、バイオテクノロジー企業が香港で株式を上場するケースが増えています。これは、香港の投資家基盤が拡大していることや、中国の製薬パートナーに近いという地理的優位性が要因です。中国市場は医薬品業界で大きな影響力を持ち、香港を拠点とすることで、この市場へのアクセスが容易になります。さらに、香港証券取引所はバイオ企業に優しい政策を持っており、資金調達や成長を促進する環境が整っています。この傾向が続くことで、香港はアジア圏のバイオテクノロジーの中心地としての地位を強化するでしょう。
Source: https://www.cnbc.com/2026/07/22/axiom-aiosciences-ipo-listing-hong-kong.html
